John Couse, PhD, Vice President, Scientific Services, Taconic Biosciences, explains how focussing on best practices for animal models can reduce a project’s timeline, budget, and total number of animals used. Research organisations engaged in drug discovery rely on animal models, including genetically engineered mice, to support and advance their preclinical work. It’s increasingly common […]